The biotechnology company reported $4.36 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.38 by $0.98.
12
Dec
Leave a Reply
You must be logged in to post a comment.
The biotechnology company reported $4.36 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.38 by $0.98.
You must be logged in to post a comment.